Highland Capital Management (Texas)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-63,000
Closed -$1.57M 295
2017
Q1
$1.57M Buy
+63,000
New +$1.53M 0.08% 172
2016
Q4
Sell
-1,238,805
Closed -$29.5M 293
2016
Q3
$29.5M Buy
1,238,805
+291,105
+31% +$6.94M 0.9% 25
2016
Q2
$22.1M Sell
947,700
-98,790
-9% -$2.14M 0.91% 28
2016
Q1
$19.7M Sell
1,046,490
-464,588
-31% -$8.16M 0.87% 29
2015
Q4
$27.9M Buy
1,511,078
+1,233,444
+444% +$22.1M 0.89% 27
2015
Q3
$4.56M Sell
277,634
-481,998
-63% -$8.24M 0.13% 149
2015
Q2
$13.4M Sell
759,632
-46,994
-6% -$840K 0.27% 87
2015
Q1
$14.3M Buy
+806,626
New +$12.7M 0.29% 79

Other funds holding BSX

Highland Capital Management (Texas)'s BSX Position: Q2 2017 in Review

Highland Capital Management (Texas) sold out of Boston Scientific (BSX) in Q2 2017, closing a stake of 63,000 shares — an estimated $1.57M sold.

Highland Capital Management (Texas) first reported a position in BSX in Q1 2015 and held it in 8 quarters. The position peaked at $29.5M in Q3 2016. 558 funds tracked by Wall St. Rank hold BSX as of Q2 2017.

  • Highland Capital Management (Texas) reported no remaining Boston Scientific position as of Q2 2017 after selling out during the quarter.
  • Highland Capital Management (Texas) sold 63,000 Boston Scientific shares in Q2 2017, an estimated $1.57M.
  • Highland Capital Management (Texas) first reported a position in Boston Scientific in Q1 2015 and held it in 8 quarters.
  • Highland Capital Management (Texas)'s Boston Scientific position peaked at $29.5M in Q3 2016.
  • 558 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2017.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2017, filed 14 Aug 2017.